Camurus' Full Year Report 2022

Fluidcrystal Injection Depot 1

Camurus' Full Year Report for 2022 was published on February 14. 2022 was the first profitable year for Camurus, driven by strong sales growth.

"We ended the year with a fourth quarter with excellent performance across the organization, strong sales momentum, positive operating results, and continued pipeline progress. Camurus reported full year profitability for the first time while also investing half a billion SEK in our R&D pipeline", says Fredrik Tiberg, President & CEO.

Read the full report on Camurus' website: 

Camurus’ Full Year Report 2022 - Camurus

Latest news


Camurus and Braeburn Pharmaceuticals announce positive Top-line results from long-term Phase 3 safety study of CAM2038

New data support long-term safety and efficacy of weekly and monthly subcutaneous buprenorphine depots in patients w…

Read more


Acquisition of Scan Coin property

On April 18, 2017 the purchase deed was signed and Sandberg Development is now the owner of the property.

Read more


Refurbishment of production facilities complete

One year after the reconstruction work started, the new production facilities were completed in March 2017.

Read more


Refurbishment of production and office facilities

In March 2016 reconstruction and extension work started at our premises on Jägershillgatan 15 in Malmö. The first pa…

Read more


Sandberg Development sponsor of Star for Life

From 2015 Sandberg Development is a sponsor of Star for Life, an educational/motivational programme, the aim of whic…

Read more